| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/13/2011 | EP2343370A1 A throbin-like enzyme of agkistrodon acutus |
| 07/13/2011 | EP2343317A1 Apolipoprotein analogues |
| 07/13/2011 | EP2343290A1 Diamine derivatives as factor X inhibitors |
| 07/13/2011 | EP2343076A1 Pharmaceutical composition for oral administration |
| 07/13/2011 | EP2343065A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 07/13/2011 | EP2343062A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 07/13/2011 | EP2343060A1 Multi-layer controlled-release tablet comprising an active layer and one or more barrier layers |
| 07/13/2011 | EP2342223A2 Modified animal erythropoietin polypeptides and their uses |
| 07/13/2011 | EP2341925A1 Composition of thrombolytic agent and anti thrombosis and also its production method |
| 07/13/2011 | EP1486491B1 Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 07/13/2011 | CN1989104B Cyclic amide derivatives, and their production and use as antithrombotic agents. |
| 07/13/2011 | CN1353609B Amide substituted imidazoquinolines |
| 07/13/2011 | CN102123707A Dabigatran for percutaneous interventional cardiac catheterisation |
| 07/13/2011 | CN102123699A Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 07/13/2011 | CN102120757A Hybrid peptide using 3S-tetrahydro-beta-carboline-3-carboxylic acid as connecting arm, and preparation method and application thereof |
| 07/13/2011 | CN102120752A Compound with effects of resisting inflammation and platelet activation and aggregation as well as preparation method and application thereof |
| 07/13/2011 | CN102120744A Optical-activity 2-hydroxytetrahydrothienopyridine derivative, preparation method and application thereof in pharmacy |
| 07/13/2011 | CN102120727A N-[(3S)-N-aminoacyl-1,2,3,4-tetrahydroisoquinoline-3-formacyl]amino acid and synthesis method and application thereof |
| 07/13/2011 | CN102120169A Sodium iron chlorophyllin-chitosan/sodium alginate microcapsules and preparation method thereof |
| 07/13/2011 | CN102120026A 21(S) argatroban intravenous injection with alcohol as solubilizer |
| 07/13/2011 | CN102119999A Preparation method of oral solution capable of tonifying qi and nourishing blood |
| 07/13/2011 | CN102119973A Quality control method for gardenia percolate |
| 07/13/2011 | CN102119928A Preparation method of lumbrokinase enteric-coated pellets |
| 07/13/2011 | CN102119925A Protein nano particle with tissue factor targeting property and preparation method and application thereof |
| 07/13/2011 | CN102119922A 21(S) Argatroban intravenous injection taking acid as solubilizer |
| 07/13/2011 | CN101695485B Use of chlorogenic acid in preparing medicament for treating thrombocytopenia and anemia |
| 07/13/2011 | CN101569749B preparation method of dextran-hemoglobin conjugate as potential blood substitute |
| 07/13/2011 | CN101518644B Application of Ang-2 and genes thereof in pharmacy |
| 07/13/2011 | CN101282926B S1p3 receptor antagonist |
| 07/13/2011 | CN101085295B Freeze dried injection containing muskone and preparation method thereof |
| 07/12/2011 | US7977506 Amino acid for delivering active materials; bioavailability |
| 07/12/2011 | US7977469 biosynthesis of long chain polyunsaturated fatty acids like DHA (docosahexaenoic acid, 22:6, n-3); stress, diabetes, cancer, inflammatory disorders, and cardiovascular disorders |
| 07/12/2011 | US7977460 Compositions comprising coagulation factors IXA and VIII for the treatment of haemophilia A or B |
| 07/12/2011 | US7977383 Containing alkali ions, electrolytes, a buffer, polyol, saccharide and hydroxamic acid derivatives |
| 07/12/2011 | US7977317 Compositions and methods for modulating blood-brain barrier transport |
| 07/12/2011 | US7976836 Treatment of stroke using placental stem cells |
| 07/12/2011 | CA2481767C Severe sepsis preventive therapeutic agent |
| 07/12/2011 | CA2461443C Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 07/12/2011 | CA2461202C Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 07/12/2011 | CA2449150C Tricyclic compounds useful as angiotensin ii agonists |
| 07/12/2011 | CA2435611C Alpha-amino-n-hydroxy-acetamide derivatives |
| 07/12/2011 | CA2397347C Factor vii or viia-like molecules |
| 07/12/2011 | CA2376375C Method and composition for inhibiting cardiovascular cell proliferation |
| 07/12/2011 | CA2362927C Novel albumin-free factor viii formulations |
| 07/12/2011 | CA2341336C Elongase genes and uses thereof |
| 07/07/2011 | WO2011081259A1 Pharmaceutical composition including a testis extract as an active ingredient for treating and preventing anemia |
| 07/07/2011 | WO2011081173A1 Tetracyclic compound |
| 07/07/2011 | WO2011080322A1 Method of prognosing the outcome of acquired hemophilia and of treatment of hemophilia |
| 07/07/2011 | WO2011079407A1 New compounds having potency to inhibit blood clotting |
| 07/07/2011 | US20110166548 Drug releasing coatings for medical devices |
| 07/07/2011 | US20110166320 Somatostatin analogues |
| 07/07/2011 | US20110166197 Antisense Modulation Of Amyloid Beta Protein Expression |
| 07/07/2011 | US20110166178 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 07/07/2011 | US20110166173 3,5-disubstututed 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors |
| 07/07/2011 | US20110166163 Substituted furopyrimidines and use thereof |
| 07/07/2011 | US20110166159 Compounds that modulate intracellular calcium |
| 07/07/2011 | US20110166145 Stabilization of hypoxia inducible factor (HIF) alpha |
| 07/07/2011 | US20110166125 Substituted amides, manufacturing and use thereof as medicaments |
| 07/07/2011 | US20110166121 Fused heterocyclic compound |
| 07/07/2011 | US20110166112 Method for stimulating platelet production |
| 07/07/2011 | US20110166104 Boron-containing small molecules |
| 07/07/2011 | US20110166078 Oligosaccharide compounds for use in mobilising stem cells |
| 07/07/2011 | US20110165249 Pharmaceutical solid preparation |
| 07/07/2011 | US20110165175 Antibody of human origin for inhibiting thrombocytes aggregation |
| 07/07/2011 | US20110165169 Complement inhibitors and uses thereof |
| 07/07/2011 | US20110165140 Dry Transglutaminase Composition |
| 07/07/2011 | US20110165064 Methods and compositions related to clot-binding compounds |
| 07/07/2011 | DE102009028929A1 Heterocyclisch-substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and their use |
| 07/06/2011 | EP2341348A1 Methods for detecting cross beta structure comprising proteins with crossbeta structure binding compounds. |
| 07/06/2011 | EP2341141A2 Recombinant platelet collagen receptor glycoprotein VI , antibodies and their pharmaceutical use |
| 07/06/2011 | EP2341078A2 Monoclonal antibody against rhesus D |
| 07/06/2011 | EP2341068A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 07/06/2011 | EP2341052A1 Ring-fused morpholine derivative having pi3k-inhibiting activity |
| 07/06/2011 | EP2340822A1 Acylated 4-amidino and 4-guanidinobenzylamines for inhibiting plasma kallikreins |
| 07/06/2011 | EP2340031A1 Use of gdf traps to increase red blood cell levels |
| 07/06/2011 | EP1537146B9 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
| 07/06/2011 | EP1317283B1 Tweak receptor agonists as anti-angiogenic agents |
| 07/06/2011 | EP1228076B1 A substantially cell membrane impermeable compound and use thereof |
| 07/06/2011 | CN1871022B Peptides and compounds that bind to a receptor |
| 07/06/2011 | CN102115478A Furo-indole compounds and preparation method and application thereof |
| 07/06/2011 | CN102115473A Bis-heterocyclic imidazolyl compounds |
| 07/06/2011 | CN102114161A Oral traditional Chinese medicine decoction for treating uterine hemorrhage |
| 07/06/2011 | CN102114157A Traditional Chinese medicine oral decoction for treating metrorrhagia |
| 07/06/2011 | CN102114135A Oral traditional Chinese medicine decoction for treating uterine hemorrhage |
| 07/06/2011 | CN102114130A Traditional Chinese medicine oral decoction for treating metrorrhagia |
| 07/06/2011 | CN102114119A Chinese medicine oral decoction for treating metrorrhagia |
| 07/06/2011 | CN102114083A Fingerprint of Polygonum multiflorum and establishment method and application thereof |
| 07/06/2011 | CN102114039A Method for processing Tibetan medicine calcite |
| 07/06/2011 | CN102114030A Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer |
| 07/06/2011 | CN102113999A Novel multi-layer polysaccharide structure-modified liposome-encapsulated hemoglobin nano-capsule blood substitute |
| 07/06/2011 | CN101874878B Chinese medicinal composition for treating hematemesis and preparation method thereof |
| 07/06/2011 | CN101703549B Atractylone lipidosome and preparation method thereof |
| 07/06/2011 | CN101693010B Cefathiamidine prosoma liposome preparation |
| 07/06/2011 | CN101653454B Medicament capable of dehydrating and withering pathological tissues |
| 07/06/2011 | CN101198614B Thienopyrimidine derivative |
| 07/05/2011 | US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/05/2011 | CA2488630C Immunoadhesin comprising a glycoprotein vi domain |
| 07/05/2011 | CA2483228C Carboxamides |
| 07/05/2011 | CA2461625C Use of irbesartan for the preparation of medicinal products that are useful for preventing or treating pulmonary hypertension |
| 07/05/2011 | CA2451866C Nutritional composition preventing bacterial overgrowth |